Current Neuropharmacology
Title:Editorial (Thematic Selection: Inflammatory and Immune Responses in Depression)
Volume: 14 Issue: 7
Author(s): Abhay Sharma
Affiliation:
Export Options
About this article
Cite this article as:
Sharma Abhay, Editorial (Thematic Selection: Inflammatory and Immune Responses in Depression), Current Neuropharmacology 2016; 14 (7) . https://dx.doi.org/10.2174/1570159X1407160826191654
DOI https://dx.doi.org/10.2174/1570159X1407160826191654 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
52
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Determination of pKa Values and Concurrent Analysis of Some Tricyclic Antidepressants in Acetonitrile-Water Mixtures
Current Pharmaceutical Analysis Anabolic Androgenic Steroids Abuse and Liver Toxicity
Mini-Reviews in Medicinal Chemistry Current Diagnostic Modalities for Vulnerable Plaque Detection
Current Pharmaceutical Design Expectancy and the Treatment of Depression: A Review of Experimental Methodology and Effects on Patient Outcome
Current Psychiatry Reviews Epigenetic Targets and their Inhibitors in Cancer Therapy
Current Topics in Medicinal Chemistry From Pyridinium-based to Centrally Active Acetylcholinesterase Reactivators
Mini-Reviews in Medicinal Chemistry Cytotoxicity and Molecular Targeting Study of Novel 2-Chloro-3- substituted Quinoline Derivatives as Antitumor Agents
Letters in Drug Design & Discovery Targeting Neuronal Nicotinic Receptors in Cancer: New Ligands and Potential Side-Effects
Recent Patents on Anti-Cancer Drug Discovery Ketamine: New Indications for an Old Drug
Current Drug Targets Sphingolipids as Emerging Drug Targets: Therapeutic Applications of Ceramide Analogs
Drug Design Reviews - Online (Discontinued) New Pharmacotherapy Targeting Cognitive Dysfunction of Schizophrenia via Modulation of GABA Neuronal Function
Current Neuropharmacology Trafficking of Neuronal Two Pore Domain Potassium Channels
Current Neuropharmacology Ligand and Structure-Based Drug Design as Strategies for the Screening of New BACE1 Inhibitor Candidates
Current Physical Chemistry Nanotechnology: Its Application in Treating Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Editorial [Hot Topic: Dopaminergic Neurotransmission (Guest Editor: Remco H.S. Westerink)]
CNS & Neurological Disorders - Drug Targets Adolescent Medication Misuse: Results from the MUSC Inventory of Medication Experiences (MIME)
Adolescent Psychiatry Hemoglobin Neurotoxicity is Attenuated by Inhibitors of the Protein Kinase CK2 Independent of Heme Oxygenase Activity
Current Neurovascular Research The Role of the Catechol-O-Methyltransferase (COMT) Gene in Personality and Related Psychopathological Disorders
CNS & Neurological Disorders - Drug Targets Editorial (Thematic Issue: GABAergic Modulation as Treatment Strategy: Consideration of Several Diseases)
Current Pharmaceutical Design Animal Models for Investigating Benign Essential Blepharospasm
Current Neuropharmacology